These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

606 related items for PubMed ID: 10391672

  • 41. The insufficient suppression of viral load by saquinavir hard gel is reversible: a retrospective cohort study.
    Jensen-Fangel S, Kirk O, Blaxhult A, Gerstoft J, Pedersen C, Black FT, Lundgren JD, Obel N.
    HIV Clin Trials; 2001; 2(2):122-7. PubMed ID: 11590520
    [Abstract] [Full Text] [Related]

  • 42. Clinical cross-resistance between the HIV-1 protease inhibitors saquinavir and indinavir and correlations with genotypic mutations.
    Schapiro JM, Winters MA, Lawrence J, Merigan TC.
    AIDS; 1999 Feb 25; 13(3):359-65. PubMed ID: 10199226
    [Abstract] [Full Text] [Related]

  • 43. The rabbit study: ritonavir and saquinavir in combination in saquinavir-experienced and previously untreated patients.
    Churchill DR, Pym AS, Galpin S, Foxall R, Stainsby C, Clarke JR, Kaye S, Bloor S, Larder BA, Wills B, Sun E, Babiker AG, Back DJ, Weber JN.
    AIDS Res Hum Retroviruses; 1999 Sep 01; 15(13):1181-9. PubMed ID: 10480631
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Randomized, controlled phase II trial of subcutaneous interleukin-2 in combination with highly active antiretroviral therapy (HAART) in HIV patients.
    Hengge UR, Goos M, Esser S, Exner V, Dötterer H, Wiehler H, Borchard C, Müller K, Beckmann A, Eppner MT, Berger A, Fiedler M.
    AIDS; 1998 Dec 03; 12(17):F225-34. PubMed ID: 9863864
    [Abstract] [Full Text] [Related]

  • 54. HIV-1 induction-maintenance at the lymph node level: the "Apollo-97" Study.
    Lafeuillade A, Poggi C, Chadapaud S, Hittinger G, Chouraqui M, Delbeke E, "Apollo-97 Study".
    J Acquir Immune Defic Syndr; 2001 Oct 01; 28(2):154-7. PubMed ID: 11588509
    [Abstract] [Full Text] [Related]

  • 55. A pilot trial of indinavir, ritonavir, didanosine, and lamivudine in a once-daily four-drug regimen for HIV infection.
    Mole L, Schmidgall D, Holodniy M.
    J Acquir Immune Defic Syndr; 2001 Jul 01; 27(3):260-5. PubMed ID: 11464145
    [Abstract] [Full Text] [Related]

  • 56. A randomized trial of nelfinavir, ritonavir, or delavirdine in combination with saquinavir-SGC and stavudine in treatment-experienced HIV-1-infected patients.
    Smith D, Hales G, Roth N, Law M, Ray J, Druett J, Mitchell J, Mills G, Doong N, Franklin R, CHRN 025 Study Group. Community HIV Research Network.
    HIV Clin Trials; 2001 Jul 01; 2(2):97-107. PubMed ID: 11590517
    [Abstract] [Full Text] [Related]

  • 57. Nucleoside analogs plus ritonavir in stable antiretroviral therapy-experienced HIV-infected children: a randomized controlled trial. Pediatric AIDS Clinical Trials Group 338 Study Team.
    Nachman SA, Stanley K, Yogev R, Pelton S, Wiznia A, Lee S, Mofenson L, Fiscus S, Rathore M, Jimenez E, Borkowsky W, Pitt J, Smith ME, Wells B, McIntosh K.
    JAMA; 2000 Jan 26; 283(4):492-8. PubMed ID: 10659875
    [Abstract] [Full Text] [Related]

  • 58. Combination antiretroviral therapy for HIV infection.
    Maenza J, Flexner C.
    Am Fam Physician; 1998 Jun 26; 57(11):2789-98. PubMed ID: 9636341
    [Abstract] [Full Text] [Related]

  • 59. Efficacy, safety, and adherence with a twice-daily combination lamivudine/zidovudine tablet formulation, plus a protease inhibitor, in HIV infection.
    Eron JJ, Yetzer ES, Ruane PJ, Becker S, Sawyer GA, Fisher RL, Tolson JM, Shaefer MS.
    AIDS; 2000 Apr 14; 14(6):671-81. PubMed ID: 10807190
    [Abstract] [Full Text] [Related]

  • 60. Resistance mutations to zidovudine and saquinavir in patients receiving zidovudine plus saquinavir or zidovudine and zalcitabine plus saquinavir in AIDS clinical trials group 229.
    Schapiro JM, Lawrence J, Speck R, Winters MA, Efron B, Coombs RW, Collier AC, Merigan TC.
    J Infect Dis; 1999 Jan 14; 179(1):249-53. PubMed ID: 9841849
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.